Inventor

MOYLE MATTHEW

US52 patents

⚠️ This page may combine multiple inventors who share the name “MOYLE MATTHEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOYLE MATTHEW

CORVAS INT INC

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Modified hookworm neutrophil inhibitors

Nematode-extracted anticoagulant protein

Nematode-extracted anticoagulant protein

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Neutrophil inhibitors

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Nematode-extracted serine protease inhibitors and anticoagulant proteins

Nematode-extracted anticoagulant protein

Nematode-extracted anticoagulant protein

Neutrophil inhibitors

Neutrophil inhibitors

Neutropohil inhibitors

Method of detecting neutophil inhibitory factor mimics

THERACLONE SCIENCES INC

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

FUNG SEK CHUNG

Anti-IL 13 antibodies and uses thereof

Treatment of cancer with novel anti-IL13 monoclonal antibodies

Anti-IL13 antibodies and uses thereof

Anti-IL13 antibodies and uses thereof

Anti-IL13 antibodies and uses thereof

Anti-IL13 antibodies and uses thereof

GENENTECH INC

Treatment of cancer with a novel anti-IL13 monoclonal antibody

Anti-IL13 antibodies and uses thereof

Beta-8 integrin subunit antibodies

Anti-IL13 antibodies and uses thereof

GRANDEA III ANDRES

Compositions and methods for the therapy and diagnosis of influenza

Compositions and methods for the therapy and diagnosis of influenza

Compositions and methods for the therapy and diagnosis of influenza

GRANDEA III ANDRES G

Compositions and methods for the therapy and diagnosis of influenza

Compositions and methods for the therapy and diagnosis of influenza

CHAN-HUI PO-YING

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

INT AIDS VACCINE INITIATIVE INC

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

DENDREON CORP

Neutrophil inhibitors

MOYLE MATTHEW

Human M2e peptide immunogens